个性化文献订阅>期刊> Bioorganic & Medicinal Chemistry Letters
 

Clinical stage EGFR inhibitors irreversibly alkylate Bmx kinase

  作者 Hur, W; Velentza, A; Kim, S; Flatauer, L; Jiang, XN; Valente, D; Mason, DE; Suzuki, M; Larson, B; Zhang, JM; Zagorska, A; DiDonato, M; Nagle, A; Warmuth, M; Balk, SP; Peters, EC; Gray, NS  
  选自 期刊  Bioorganic & Medicinal Chemistry Letters;  卷期  2008年18-22;  页码  5916-5919  
  关联知识点  
 

[摘要]Irreversible HER/erbB inhibitors selectively inhibit HER-family kinases by targeting a unique cysteine residue located within the ATP-binding pocket. Sequence alignment reveals that this rare cysteine is also present in ten other protein kinases including all five Tec-family members. We demonstrate that the Tec-family kinase Bmx is potently inhibited by irreversible modi. cation at Cys496 by clinical stage EGFR inhibitors such as CI-1033. This cross-reactivity may have significant clinical implications. (C) 2008 Elsevier Ltd. All rights reserved.

 
      被申请数(0)  
 

[全文传递流程]

一般上传文献全文的时限在1个工作日内